Researchers are saying that, from an infection control perspective, C. auris acts more like a multidrug-resistant, healthcare-associated bacteria than like a typical yeast, according to an article on the MedPage website.
"It is a new bug using old tricks mastered by some well-known, multidrug resistant organisms," they said.
Identifying, treating, and preventing Candida auris is a challenge facing more and more healthcare settings.
Findings presented at the 2019 ASM Microbe meeting in San Francisco by researchers from the Centers for Disease Control and Prevention found that patients with C. auris appear to "shed" the pathogen from their skin into their environment, which could potentially play a factor in transmission.
The Role of Positive Distraction in Pediatric Design
Healthcare Waste is Fueling America's Debt
Prairie Lakes Healthcare System to Rebrand Following Sanford Health Merger
How Digital Technologies Are Reshaping Performance in Healthcare Facilities
The Role of Plumbing in Healthcare-Associated Infections